Log In
Print
BCIQ
Print
Print this Print this
 

MEDI-559

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionLive attenuated respiratory syncytial virus (RSV) vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationRespiratory syncytial virus (RSV)
Indication DetailsPrevent severe respiratory syncytial virus (RSV) infections in children
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today